Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Non Operating Income (2018 - 2025)

Arcturus Therapeutics Holdings (ARCT) has disclosed Other Non Operating Income for 8 consecutive years, with -$8.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non Operating Income fell 354.82% year-over-year to -$8.2 million, compared with a TTM value of $382000.0 through Dec 2025, down 97.49%, and an annual FY2025 reading of $382000.0, down 97.49% over the prior year.
  • Other Non Operating Income was -$8.2 million for Q4 2025 at Arcturus Therapeutics Holdings, down from $3.2 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $24.2 million in Q4 2023 and bottomed at -$8.2 million in Q4 2025.
  • Average Other Non Operating Income over 5 years is $2.4 million, with a median of $1.5 million recorded in 2022.
  • The sharpest move saw Other Non Operating Income plummeted 1440.91% in 2021, then skyrocketed 9461.54% in 2022.
  • Year by year, Other Non Operating Income stood at -$339000.0 in 2021, then crashed by 978.76% to -$3.7 million in 2022, then skyrocketed by 762.92% to $24.2 million in 2023, then tumbled by 86.74% to $3.2 million in 2024, then plummeted by 354.82% to -$8.2 million in 2025.
  • Business Quant data shows Other Non Operating Income for ARCT at -$8.2 million in Q4 2025, $3.2 million in Q3 2025, and $5.4 million in Q2 2025.